Author:
Braido F.,Bousquet P. J.,Brzoza Z.,Canonica G. W.,Compalati E.,Fiocchi A.,Fokkens W.,Gerth van Wijk R.,La Grutta S.,Lombardi C.,Maurer M.,Pinto A. M.,Ridolo E.,Senna G. E.,Terreehorst I.,Todo Bom A.,Bousquet J.,Zuberbier T.,Baiardini I.
Subject
Immunology,Immunology and Allergy
Reference119 articles.
1. Patient-reported outcomes to support medical product labeling claims: FDA perspective;Patrick;Value Health,2007
2. Guidance for Industry: patient reported outcome measures: use in medical product development to support labelling claims: draft guidance;US Department of Health and Human Services FDA Center for Drug Evaluation and Research, US Department of Health and Human Services FDA Center for Biologics Evaluation and Research and US Department of Health and Human Services FDA Center for Devices and Radiological Health;Health Qual Life Outcomes,2006
3. European Medicines Agency. Committee for medicinal products for human use (CHMP) Reflection paper on the regulatory guidance for the use of health-related quality of life (HROL) measures in the evaluation of medicinal products http://www.emea.europa.eu/pdfs/human/ewp/13939104en.pdf
4. ARIA suggested drugs for allergic rhinitis: what impact on quality of life? A GA2LEN Review;Baiardini;Allergy,2008
5. The impact of GINA suggested drugs for the treatment of asthma on Health-Related Quality of Life: a GA2LEN review;Baiardini;Allergy,2008
Cited by
62 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献